HARVARD BIOSCIENCE, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
HARVARD BIOSCIENCE, INC. (HBIO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 40.34 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-11
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 40.77M shares, a 4.69% increase year-over-year.
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 40.75M shares, a 4.71% increase year-over-year.
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 40.15M shares, a 4.38% increase year-over-year.
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 39.79M shares, a 3.80% increase year-over-year.
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 40.34M shares, a 4.41% increase from fiscal 2020.
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 38.64M shares, a 2.18% increase from fiscal 2019.
- HARVARD BIOSCIENCE, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 37.81M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 40.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 40.76M shares derived: average of 2 quarters · filed 2022-03-11 | 40.56M shares derived: average of 3 quarters · filed 2022-03-11 | 40.34M shares 10-K · filed 2022-03-11 |
| 2021-09-30 | 40.75M shares 10-Q · filed 2021-11-05 | 40.45M shares derived: average of 2 quarters · filed 2021-11-05 | 40.20M shares 10-Q · filed 2021-11-05 | 39.91M shares derived: average of 4 quarters · filed 2022-03-11 |
| 2021-06-30 | 40.15M shares 10-Q · filed 2021-08-06 | 39.96M shares 10-Q · filed 2021-08-06 | 39.63M shares derived: average of 3 quarters · filed 2022-03-11 | 39.45M shares derived: average of 4 quarters · filed 2022-03-11 |
| 2021-03-31 | 39.79M shares 10-Q · filed 2021-05-07 | 39.36M shares derived: average of 2 quarters · filed 2022-03-11 | 39.22M shares derived: average of 3 quarters · filed 2022-03-11 | 39.03M shares derived: average of 4 quarters · filed 2022-03-11 |
| 2020-12-31 | 38.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 38.93M shares derived: average of 2 quarters · filed 2022-03-11 | 38.78M shares derived: average of 3 quarters · filed 2022-03-11 | 38.64M shares 10-K · filed 2022-03-11 |
| 2020-09-30 | 38.92M shares 10-Q · filed 2021-11-05 | 38.69M shares derived: average of 2 quarters · filed 2021-11-05 | 38.54M shares 10-Q · filed 2021-11-05 | 38.42M shares derived: average of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | 38.47M shares 10-Q · filed 2021-08-06 | 38.39M shares 10-Q · filed 2021-08-06 | 38.25M shares derived: average of 3 quarters · filed 2021-08-06 | 38.20M shares derived: average of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | 38.33M shares 10-Q · filed 2021-05-07 | 38.15M shares derived: average of 2 quarters · filed 2021-05-07 | 38.11M shares derived: average of 3 quarters · filed 2021-05-07 | |
| 2019-12-31 | 37.96M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | 38.00M shares derived: average of 2 quarters · filed 2021-03-17 | 37.81M shares 10-K/A · filed 2021-03-17 | |
| 2019-09-30 | 38.04M shares 10-Q · filed 2020-11-06 | 37.76M shares 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |